sur Financial Conduct Authority
Roquefort Therapeutics plc Delisted from Official List
The Financial Conduct Authority (FCA) has removed Roquefort Therapeutics plc's securities from the Official List as of March 27, 2026, at 08:00 GMT. The delisted securities include ordinary shares of 1p each, fully paid, under the ISIN code GB00BMDQ2T15. This action signifies a significant regulatory change affecting the company's presence on the market.
The ordinary shares were previously part of the equity shares category (transition) on the London Stock Exchange, an acknowledged investment platform. Investors and stakeholders are informed to take note of this change, which could impact trading perceptions and strategies related to Roquefort Therapeutics plc.
This notice has been disseminated by Listings Data Management and underlines the crucial need for investors to stay updated with official announcements from recognised investment exchanges and the FCA regarding securities admissions and removals.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Financial Conduct Authority